MX2007007427A - Composicion que comprende adapaleno solubilizado con ciclodextrinas. - Google Patents
Composicion que comprende adapaleno solubilizado con ciclodextrinas.Info
- Publication number
- MX2007007427A MX2007007427A MX2007007427A MX2007007427A MX2007007427A MX 2007007427 A MX2007007427 A MX 2007007427A MX 2007007427 A MX2007007427 A MX 2007007427A MX 2007007427 A MX2007007427 A MX 2007007427A MX 2007007427 A MX2007007427 A MX 2007007427A
- Authority
- MX
- Mexico
- Prior art keywords
- adapalene
- cyclodextrins
- solubilized
- composition
- dermatology
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Nanotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invencion se refiere a una composicion que comprende adapaleno solubilizado en un medio acuoso con ciclodextrinas o derivados de las mismas, a su procedimiento de preparacion y a su utilizacion en cosmetica y dermatologia.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0413760A FR2879459B1 (fr) | 2004-12-22 | 2004-12-22 | Composition comprenant de l'adapalene solubilise avec des cyclodextrines |
PCT/FR2005/003173 WO2006070093A1 (fr) | 2004-12-22 | 2005-12-16 | Composition comprenant de i'adapalene solubilise avec des cyclodextrines |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007007427A true MX2007007427A (es) | 2008-01-14 |
Family
ID=34951824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007007427A MX2007007427A (es) | 2004-12-22 | 2005-12-16 | Composicion que comprende adapaleno solubilizado con ciclodextrinas. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20080008727A1 (es) |
EP (1) | EP1830795A1 (es) |
JP (1) | JP2008525385A (es) |
KR (1) | KR20070090205A (es) |
CN (1) | CN101087581A (es) |
AU (1) | AU2005321158A1 (es) |
BR (1) | BRPI0517495A (es) |
CA (1) | CA2591294A1 (es) |
FR (1) | FR2879459B1 (es) |
MX (1) | MX2007007427A (es) |
RU (1) | RU2007127992A (es) |
WO (1) | WO2006070093A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5125122B2 (ja) * | 2007-01-31 | 2013-01-23 | 大正製薬株式会社 | アダパレン含有外用剤組成物 |
JP5233149B2 (ja) * | 2007-03-31 | 2013-07-10 | 大正製薬株式会社 | アダパレン含有外用剤組成物 |
JP5061984B2 (ja) * | 2007-03-31 | 2012-10-31 | 大正製薬株式会社 | アダパレン含有外用剤組成物 |
FR2916975B1 (fr) * | 2007-06-11 | 2009-09-04 | Galderma Res & Dev | Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations |
FR2916966B1 (fr) * | 2007-06-11 | 2011-01-14 | Galderma Res & Dev | Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations |
FR2944207B1 (fr) | 2009-04-09 | 2011-05-06 | Galderma Res & Dev | Compositions comprenant au moins un complexe compose d'un derive d'acide naphtoique et d'au moins une cyclodestrine et leurs utilisations |
FR2944280B1 (fr) * | 2009-04-09 | 2012-08-03 | Galderma Res & Dev | Procede de preparation de complexes moleculaires entre adapalene et des cyclodextrines |
US8802653B2 (en) * | 2010-10-01 | 2014-08-12 | C.B. Fleet Company, Inc. | Deodorant compositions |
US8685380B2 (en) | 2010-10-25 | 2014-04-01 | C.B. Fleet Company, Inc. | Deodorant spray |
WO2014159659A1 (en) * | 2013-03-12 | 2014-10-02 | Stein Emily A | Dental composition comprising chelator and base |
FR3018192B1 (fr) * | 2014-03-06 | 2017-09-01 | Laboratoires M&L | Composition cosmetique comprenant de la gomme de sclerotium (sclerotium gum) |
EP3475312B1 (en) | 2016-06-23 | 2020-05-27 | Galderma S.A. | Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereof |
CN113577013B (zh) * | 2020-10-23 | 2023-12-22 | 南京欣通瑞亿医药科技有限公司 | 一种含有氨苯砜类化合物的经皮给药组合物及其制备方法 |
KR102608639B1 (ko) * | 2021-01-27 | 2023-12-01 | 주식회사 티엠에스헬스케어 | 캡슐화케라틴의 제조방법 및 이의 방법으로 제조된 캡술화케라틴을 포함하는 피부장벽 개선용 화장료 조성물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4371673A (en) * | 1980-07-21 | 1983-02-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble forms of retinoids |
AU670777B2 (en) * | 1992-04-16 | 1996-08-01 | Ortho Pharmaceutical Corporation | Aqueous gel vehicles for retinoids |
AU5132799A (en) * | 1998-07-28 | 2000-02-21 | Bershad, Susan | Short contact treatment of acne and photoaging with topical retinoids |
US6048902A (en) * | 1999-02-12 | 2000-04-11 | Lebwohl; Mark G. | Short contact treatment of psoriasis with topical retinoids |
US6322801B1 (en) * | 1999-08-02 | 2001-11-27 | The Procter & Gamble Company | Personal care articles |
JP2005526063A (ja) * | 2002-03-12 | 2005-09-02 | ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ | 皮膚疾患を治療するためのアダパレンの使用 |
EP1449514A1 (de) * | 2003-02-13 | 2004-08-25 | Beiersdorf AG | Hautpflegeprodukte mit Retinoiden, Ubichinonen sowie Biotin oder Carnitin |
-
2004
- 2004-12-22 FR FR0413760A patent/FR2879459B1/fr not_active Expired - Fee Related
-
2005
- 2005-12-16 JP JP2007547563A patent/JP2008525385A/ja active Pending
- 2005-12-16 EP EP05849276A patent/EP1830795A1/fr not_active Withdrawn
- 2005-12-16 MX MX2007007427A patent/MX2007007427A/es not_active Application Discontinuation
- 2005-12-16 KR KR1020077014179A patent/KR20070090205A/ko not_active Application Discontinuation
- 2005-12-16 RU RU2007127992/15A patent/RU2007127992A/ru not_active Application Discontinuation
- 2005-12-16 BR BRPI0517495-3A patent/BRPI0517495A/pt not_active IP Right Cessation
- 2005-12-16 WO PCT/FR2005/003173 patent/WO2006070093A1/fr active Application Filing
- 2005-12-16 CA CA002591294A patent/CA2591294A1/fr not_active Abandoned
- 2005-12-16 CN CNA2005800444552A patent/CN101087581A/zh active Pending
- 2005-12-16 AU AU2005321158A patent/AU2005321158A1/en not_active Abandoned
-
2007
- 2007-06-22 US US11/812,889 patent/US20080008727A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101087581A (zh) | 2007-12-12 |
RU2007127992A (ru) | 2009-01-27 |
US20080008727A1 (en) | 2008-01-10 |
BRPI0517495A (pt) | 2008-10-07 |
FR2879459A1 (fr) | 2006-06-23 |
JP2008525385A (ja) | 2008-07-17 |
WO2006070093A1 (fr) | 2006-07-06 |
KR20070090205A (ko) | 2007-09-05 |
EP1830795A1 (fr) | 2007-09-12 |
CA2591294A1 (fr) | 2006-07-06 |
FR2879459B1 (fr) | 2007-02-16 |
AU2005321158A1 (en) | 2006-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007007427A (es) | Composicion que comprende adapaleno solubilizado con ciclodextrinas. | |
WO2006069998A3 (de) | Glycopyrrolat in kosmetischen zubereitungen | |
MX272846B (es) | Dispersion acuosa, metodo de produccion y su uso. | |
WO2007041584A3 (en) | Implantable sensors, implantable pumps, and anti-scarring drug combinations | |
WO2008039341A3 (en) | Sterilizing cutting system | |
WO2010002586A3 (en) | Topical compositions comprising isonicotinamide | |
AU303542S (en) | Metal extrusion for tilework | |
WO2006072015A3 (en) | Organometallic complexes | |
ZA200700680B (en) | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof | |
WO2004021967A3 (en) | Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent | |
IL176513A0 (en) | Diarylmethyl piperazine derivatives, preparations thereof and used thereof | |
WO2006120133A3 (en) | Process for coloring keratin fibers comprising metal complexes | |
MXPA06002882A (es) | Dispersiones de adhesivo acuosas. | |
MX2009003060A (es) | Emulsion. | |
AU2003276081A1 (en) | Aqueous polymer dispersions containing alkyldiketenes, methods for the production thereof, and their use | |
MX2007007355A (es) | 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor. | |
CA105215S (en) | Packaging with cosmetic composition | |
AU2001273999A1 (en) | Fluorescein isothiocyanate (fitc) sinistrin, its production and use | |
WO2006134279A3 (fr) | Procede de solubilisation du metronidazole a l’aide de niacinamide et de deux glycols, solution ainsi obtenue | |
WO2006116076A3 (en) | Tab molecules | |
GB0525944D0 (en) | Water-soluble isoflavone composition, process for producing the same, and use thereof | |
MXPA03001557A (es) | Derivados bifenilo. | |
MY139010A (en) | 6-azo-5, 5'-dihydroxy -7,7'-disulfo-2-2'-dinaphthylamine derivatives | |
IL156162A0 (en) | Coniosetin and derivatives thereof, method for producing the same and use thereof. | |
IL188185A0 (en) | Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |